This mechanism has been shown to be responsible for the sustained proliferation of cells deficient in promyelocytic leukemia protein (PML), a tumor suppressor present at the MAMs that augments ER–mitochondrial Ca2+ flux on the one hand and excessive chemotherapeutic resistance on the other hand (71, 72). The gene discussed is PML; the disease is neoplasm.